beyond spring pharmaceuticals stock

According to the release plinabulin is a. Ad Exposure to Highly Liquid Companies Pharmaceutical Industry Leaders.

Beyondspring Bysi Market Capitalization

Lan Huang Beyond Springs co-founder chairman and chief executive officer.

. Wanchunbulin which owns a 100 interest in plinabulin. Find a Dedicated Financial Advisor Now. Is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies.

The Companyâs lead product Plinabulin which is being studied as an anti-cancer agent in combination with docetaxel in advanced non. BYSI a global pharmaceutical company focused on the development of cancer therapeutics today announced the presentation of preclinical data in patient-derived PDX cancer models supporting the use of plinabulin in. Find the latest Inovio Pharmaceuticals Inc.

Ad Learn more about PILL - The Direxion Daily 3X PharmaMedical ETF. On average they anticipate BeyondSprings stock price to reach 3000 in the next year. BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulins Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and Exposition.

Ad Build Your Portfolio Your Way. Beyond spring pharmaceuticals stock Sunday March 6 2022 Edit. Searching for Financial Security.

Bysi Stock Nearly Triples On Positive Results Of Cancer Treatment Trial. BYSI a global pharmaceutical company focused on the development of cancer therapeutics today will have a late-breaking oral presentation at the European Society for Medical Oncology 2021 Congress. The pharmaceutical company announced that its drug plinabulin met the primary and key secondary endpoints during a registrational trial.

This suggests a possible upside of 12699 from the stocks current price. BYSI Q4 2021 Earnings Call Transcript. Events presentations.

1 We own global rights to plinabulin in all countries except China. Stock news by MarketWatch. Choose Investments Using 0 Online Stock and ETF Trades.

Tap the sections below to expand or download the full pipeline chart. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with the University of Washington in de novo drug discovery using a. BeyondSpring Pharmaceuticals announced new data highlighting the mechanism of action of plinabulin in the prevention of chemotherapy-induced neutropenia CIN at the 63rd American Society of Hematology ASH Annual Meeting and Exposition held virtually and in person in Atlanta Georgia from December 11 2021 to December 14 2021.

Sign Up to Receive the Latest News Insights About Pharmaceutical Investing. 20 2021 GLOBE NEWSWIRE -- BeyondSpring Pharmaceuticals the Company or BeyondSpring NASDAQ. In China we own a 5797 interest in our Chinese subsidiary Dalian Wanchunbulin Pharmaceuticals Ltd.

And China for the prevention of CIN with a US. View analysts price targets for BeyondSpring or view top-rated stocks among Wall Street analysts. Beyondspring Inc stock is up 3400 over the last 12 months and the average rating from Wall Street analysts is a Strong BuyInvestorsObservers proprietary ranking system gives BYSI stock a score of 82 out of a possible 100.

BYSIs rank also includes a fundamental score of 84. Volume is the number of shares traded in a given period. The Closing Price Days High Days Low and Days Volume have been adjusted to account for any stock splits andor dividends which may have occurred for this security since the date shown above.

Ad 0 Commissions Online Specialized Trade Platforms Satisfaction Guarantee. That rank is primarily influenced by a long-term technical score of 97. BYSI Complete BeyondSpring Inc.

Their forecasts range from 500 to 6500. Our Financial Advisors Offer a Wealth of Knowledge. NEW YORK Oct.

By the close of. PDUFA date of November 30 2021NEW YORK. Discover our most recent and upcoming events as well as download informative presentationsall right here.

Adding plinabulin to a myelosuppressive chemotherapy regimen rapidly reversed within 24 hours chemotherapy. Plinabulin in combination with G-CSF is undergoing regulatory review for potential approval in the US. Joining us on todays call is Dr.

View real-time stock prices and stock quotes for a full financial overview. Stock futures are sliding in early morning trading at the start of this trading week. The Actual Price is not adjusted for splits or dividends.

NEW YORK September 20 2021 GLOBE NEWSWIRE - BeyondSpring Pharmaceuticals the Company or BeyondSpring NASDAQ. Shares of BeyondSpring BYSI -988 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung cancer treatment. Ad Ensure Your Investments Align with Your Goals.

Cancer Specialist Beyondspring Lands On The Nasdaq With A 54m Ipo Fierce Biotech

Beyondspring Pharmaceuticals Receives Complete Response Letter From The Fda For Plinabulin New Drug Application For Prevention Of Chemotherapy Induced Neutropenia Cin